Mark E. Stearns
Impact in
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms
- Oncology top 2%
- Peptidase Inhibition and Analysis
- Bone health and treatments
- Cancer Treatment and Pharmacology
- Chemokine receptors and signaling
Papers in
- Oncology 27
- Bone health and treatments 6
- Cancer Treatment and Pharmacology 5
-
- Protease and Inhibitor Mechanisms 13
- Co-authors
- Kenneth D. Tew (7 shared papers)Min Wang (3 shared papers)Min Wang (7 shared papers)Kim Fudge (4 shared papers)David L. Brown (4 shared papers)Min Wang (1 shared paper)Muxue Wang (1 shared paper)Olimpia Meucci (2 shared papers)
- Journals
- The Prostate (8 papers)Clinical & Experimental Metastasis (4 papers)The Journal of Cell Biology (4 papers)Journal of Cell Science (3 papers)Pharmacology & Therapeutics (2 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Mark E. Stearns
73 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 110
- Cancer Research 643
- Oncology 974
- Immunology and Allergy 182
- Cell Biology 361
- Applied Microbiology and Biotechnology 35
Countries citing papers authored by Mark E. Stearns
This map shows the geographic impact of Mark E. Stearns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Stearns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Stearns more than expected).
Fields of papers citing papers by Mark E. Stearns
This network shows the impact of papers produced by Mark E. Stearns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Stearns. The network helps show where Mark E. Stearns may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Stearns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 177 | |
| 2 | Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue. | 1993 | 165 |
| 3 | 1997 | 150 | |
| 4 | 1999 | 146 | |
| 5 | Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. | 1999 | 112 |
| 6 | 1991 | 102 | |
| 7 | 1987 | 96 | |
| 8 | Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. | 1992 | 90 |
| 9 | 1996 | 73 | |
| 10 | 1988 | 70 | |
| 11 | 1982 | 68 | |
| 12 | 2010 | 66 | |
| 13 | 2011 | 65 | |
| 14 | 1988 | 64 | |
| 15 | Effects of alendronate and taxol on PC-3 ML cell bone metastases in SCID mice. | 1996 | 64 |
| 16 | 2005 | 58 | |
| 17 | 2009 | 58 | |
| 18 | Antimicrotubule effects of estramustine, an antiprostatic tumor drug. | 1985 | 57 |
| 19 | Decreased expression of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in invasive cell clones derived from human prostate and breast tumor cells. | 1994 | 55 |
| 20 | 1987 | 54 |
About Mark E. Stearns
Mark E. Stearns is a scholar working on Oncology, Cancer Research, Cell Biology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 74 papers that have together received 2.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (18 papers), Microtubule and mitosis dynamics (15 papers), Protease and Inhibitor Mechanisms (13 papers), Ubiquitin and proteasome pathways (9 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Bone health and treatments (6 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Cancer Research (643 citations), Oncology (974 citations), Immunology and Allergy (182 citations), Cell Biology (361 citations) and Applied Microbiology and Biotechnology (35 citations). Mark E. Stearns has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Kenneth D. Tew, Min Wang, Min Wang, Kim Fudge, David L. Brown, Min Wang, Muxue Wang, Olimpia Meucci, Nathan G. Dolloff and Alessandro Fatatis. Their work appears in journals such as The Prostate, Clinical & Experimental Metastasis, The Journal of Cell Biology, Journal of Cell Science and Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.